Go
Print

Chapter 70.14 RCW

HEALTH CARE SERVICES PURCHASED BY STATE AGENCIES

Sections

HTMLPDF 70.14.020State agencies to identify alternative health care providers.
HTMLPDF 70.14.030Health care utilization review procedures.
HTMLPDF 70.14.040Review of prospective rate setting methods.
HTMLPDF 70.14.050Drug purchasing cost controls—Establishment of evidence-based prescription drug program.
HTMLPDF 70.14.060Prescription drug purchasing consortium—Participation—Exceptions—Rules.
HTMLPDF 70.14.065Generic prescription drug partnership agreements.
HTMLPDF 70.14.070Prescription drug consortium account.
HTMLPDF 70.14.080Definitions.
HTMLPDF 70.14.090Health technology clinical committee.
HTMLPDF 70.14.100Health technology selection and assessment.
HTMLPDF 70.14.110Health technology clinical committee determinations.
HTMLPDF 70.14.120Agency compliance with committee determination—Coverage and reimbursement determinations for nonreviewed health technologies—Appeals.
HTMLPDF 70.14.130Health technology clinical committee—Public notice.
HTMLPDF 70.14.140Applicability to health care services purchased from health carriers.
HTMLPDF 70.14.150Data-sharing agreements—Report.
HTMLPDF 70.14.155Streamlined health care administration—Agency participation.
HTMLPDF 70.14.160Total cost of insulin work group—Appointment—Duties—Reporting.
HTMLPDF 70.14.165Total cost of insulin work group—Authority implementation.
HTMLPDF 70.14.170Opioid overdose reversal medications—Bulk purchasing and distribution—Rules—Report—Recommendation to legislature.
HTMLPDF 70.14.175Opioid overdose reversal medication account.

NOTES:

State health care cost containment policies: RCW 43.41.160.
Site Contents
Selected content listed in alphabetical order under each group



Translate